Bilian Huang

Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)

Zhiwei Wu, Qinxue Hu, Yalan Liu, 2022, bioRxiv.

AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia

Zhiwei Wu, Yanlei Li, Waqas Nawaz, 2021, Blood cancer journal.

Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)

Zhiwei Wu, Qinxue Hu, Yalan Liu, 2021, bioRxiv.

Development of functional anti‐Gn nanobodies specific for SFTSV based on next‐generation sequencing and proteomics

Jingzi Zhang, Lei Fang, Yibing Ding, 2022, Protein science : a publication of the Protein Society.

A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo.

Zhiwei Wu, Yanlei Li, Waqas Nawaz, 2020, JCI insight.

AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia

Zhiwei Wu, Yanlei Li, Waqas Nawaz, 2021, Blood Cancer Journal.

Nanotechnology and Immunoengineering: How nanotechnology can boost CAR-T therapy.

Waqas Nawaz, Zhiwei Wu, Yanlei Li, 2020, Acta biomaterialia.

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration

Zhiwei Wu, Ping Yang, Qinxue Hu, 2021, bioRxiv.

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Zhiwei Wu, Doudou Zhang, Hongxia Wei, 2021, Frontiers in Immunology.